Literature DB >> 23993001

Comparison of multicenter registries and randomized control trials for transcatheter aortic valve replacement (TAVR).

Shikhar Agarwal1, E Murat Tuzcu, William Stewart, Navkaranbir Singh Bajaj, Lars G Svensson, Samir R Kapadia.   

Abstract

BACKGROUND: TAVR has emerged as an attractive alternative for treatment of severe aortic stenosis in high risk surgical patients. Despite several large multicenter registries, only one randomized trial (PARTNER) has been published.
OBJECTIVE: We aimed to compare the outcomes obtained using multicenter registries and the PARTNER trial.
METHODS: Standard MEDLINE search strategy was used to find multicenter registries, reporting clinical outcomes following TAVR. Meta-analytic techniques were utilized to calculate pooled outcomes across multicenter registries and compare them to outcomes in PARTNER trial.
RESULTS: Pooled 30-day mortality rate from the registries was 9.2%, which was significantly higher than that in the PARTNER trial (3.8%). Medium-term mortality rates were similar between the PARTNER trial and the multicenter registries. Pooled 30-day and 1-year stroke rates in multicenter registries were 2.6% and 3.8%, respectively. On the other hand, the corresponding rates in PARTNER trial were 5.2% and 7.6%, respectively. In the registry-related cohorts, pooled 30-day and 1-year mortality rates were 6.8% and 20.8% in the transfemoral group and 12.2% and 32.2% in the transapical group. In the PARTNER trial, the pooled incidence of 30-day and 1-year mortality rates were 3.9% and 26.2% in the transfemoral group and 3.8% and 29.0% in the transapical group.
CONCLUSIONS: Short-term results in PARTNER were better than those reported in the registries, which may be due to better patient selection and aggressive bailout techniques. Similarity of medium-term outcomes between registries and PARTNER highlights that patient selection for TAVR is critical due to considerable risk of mortality in the first year even after the successful procedure.
Copyright © 2013 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Meta-analysis; Multicenter registries; Randomized control trials; Transcatheter aortic valve replacement

Mesh:

Year:  2013        PMID: 23993001      PMCID: PMC3860977          DOI: 10.1016/j.ihj.2013.06.007

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  39 in total

1.  Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis.

Authors:  Hasan Jilaihawi; Derek Chin; Mariuca Vasa-Nicotera; Mohamed Jeilan; Tomasz Spyt; G Andre Ng; Johan Bence; Elaine Logtens; Jan Kovac
Journal:  Am Heart J       Date:  2009-05       Impact factor: 4.749

2.  Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis.

Authors:  Jan Baan; Ze Yie Yong; Karel T Koch; José P S Henriques; Berto J Bouma; Marije M Vis; Riccardo Cocchieri; Jan J Piek; Bas A J M de Mol
Journal:  Am Heart J       Date:  2010-03       Impact factor: 4.749

3.  Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study.

Authors:  Philipp Kahlert; Stephan C Knipp; Marc Schlamann; Matthias Thielmann; Fadi Al-Rashid; Marcel Weber; Uwe Johansson; Daniel Wendt; Heinz G Jakob; Michael Forsting; Stefan Sack; Raimund Erbel; Holger Eggebrecht
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

4.  Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.

Authors:  Martyn Thomas; Gerhard Schymik; Thomas Walther; Dominique Himbert; Thierry Lefèvre; Hendrik Treede; Holger Eggebrecht; Paolo Rubino; Iassen Michev; Rüdiger Lange; William N Anderson; Olaf Wendler
Journal:  Circulation       Date:  2010-06-21       Impact factor: 29.690

5.  Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience.

Authors:  Josep Rodés-Cabau; John G Webb; Anson Cheung; Jian Ye; Eric Dumont; Christopher M Feindel; Mark Osten; Madhu K Natarajan; James L Velianou; Giuseppe Martucci; Benoît DeVarennes; Robert Chisholm; Mark D Peterson; Samuel V Lichtenstein; Fabian Nietlispach; Daniel Doyle; Robert DeLarochellière; Kevin Teoh; Victor Chu; Adrian Dancea; Kevin Lachapelle; Asim Cheema; David Latter; Eric Horlick
Journal:  J Am Coll Cardiol       Date:  2010-01-22       Impact factor: 24.094

6.  Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement.

Authors:  Daniel Wendt; Brigitte R Osswald; Katrin Kayser; Matthias Thielmann; Paschalis Tossios; Parwis Massoudy; Markus Kamler; Heinz Jakob
Journal:  Ann Thorac Surg       Date:  2009-08       Impact factor: 4.330

7.  Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval.

Authors:  Nicolo Piazza; Eberhard Grube; Ulrich Gerckens; Peter den Heijer; Axel Linke; Olev Luha; Angelo Ramondo; Giampaolo Ussia; Peter Wenaweser; Stephan Windecker; Jean-Claude Laborde; Peter de Jaegere; Patrick W Serruys
Journal:  EuroIntervention       Date:  2008-08       Impact factor: 6.534

8.  Adherence to patient selection criteria in patients undergoing transcatheter aortic valve implantation with the 18F CoreValve ReValving System.

Authors:  N Piazza; A Otten; C Schultz; Y Onuma; H M Garcia-Garcia; E Boersma; P de Jaegere; P W Serruys
Journal:  Heart       Date:  2009-09-10       Impact factor: 5.994

9.  Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve.

Authors:  Nicolo Piazza; Yoshinobu Onuma; Emile Jesserun; Peter Paul Kint; Anne-Marie Maugenest; Robert H Anderson; Peter P Th de Jaegere; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2008-06       Impact factor: 11.195

10.  The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery.

Authors:  Sean M O'Brien; David M Shahian; Giovanni Filardo; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Sharon-Lise T Normand; Elizabeth R DeLong; Cynthia M Shewan; Rachel S Dokholyan; Eric D Peterson; Fred H Edwards; Richard P Anderson
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

View more
  4 in total

Review 1.  Transcatheter aortic valve replacement with a focus on transcarotid: a review of the current literature.

Authors:  Issa Pour-Ghaz; Joel Raja; Mahmoud Bayoumi; Theodore Manolukas; Rami N Khouzam; Uzoma N Ibebuogu
Journal:  Ann Transl Med       Date:  2019-09

Review 2.  Non-transfemoral access sites for transcatheter aortic valve replacement.

Authors:  Mariah Madigan; Rony Atoui
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 3.  Choice and Selection of Treatment Modalities for Cardiac Patients: An Interventional Cardiology Perspective.

Authors:  Shikhar Agarwal; E Murat Tuzcu; Samir R Kapadia
Journal:  J Am Heart Assoc       Date:  2015-10-20       Impact factor: 5.501

4.  Comparison of transesophageal and transthoracic echocardiography under moderate sedation for guiding transcatheter aortic valve replacement.

Authors:  Ines Sherifi; Alaa Mabrouk Salem Omar; Mithun Varghese; Menachem Weiner; Ani Anyanwu; Jason C Kovacic; Samin Sharma; Annapoorna Kini; Partho P Sengupta
Journal:  Echo Res Pract       Date:  2018-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.